TRUHVaneck Healthcare TruSector ETF
Seeks long-term capital appreciation.
By VanEck · Launched 2026
Annual Cost
0.10%
#429 of 6,040 · low cost
Fund Size
$0.6M
#5,876 of 6,040 · small
Return (1Y)
N/A
Track Record
5 months
#5,322 of 6,040 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,592+15.9%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
Top 10 holdings = 61.0% of fundconcentrated
Eli Lilly and CoLLY
15.2%
Johnson & JohnsonJNJ
10.5%
AbbVie IncABBV
7.3%
Merck & Co IncMRK
5.9%
UnitedHealth Group IncUNH
5.8%
Amgen IncAMGN
3.8%
Thermo Fisher Scientific IncTMO
3.8%
Abbott LaboratoriesABT
3.2%
Gilead Sciences IncGILD
3.0%
Pfizer IncPFE
2.6%
Asset allocation
Stocks
100.1%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-5.7%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Actively manages a portfolio primarily invested in equity securities of U.S. healthcare-related companies, focusing on large- and medium-capitalization firms. The Adviser favors well-established market leaders and may use derivatives for exposure, with a concentration in the healthcare sector.
- Inception date
- April 1, 2026
- Fund family
- VanEck
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save TRUH to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18